Ultragenyx Pharmaceutical, Inc. (RARE)
36.45
+0.07
(+0.19%)
USD |
NASDAQ |
Dec 08, 16:00
36.70
+0.25
(+0.69%)
After-Hours: 05:25
Ultragenyx Pharmaceutical Shareholders Equity (Quarterly): 9.159M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Amicus Therapeutics, Inc. | 230.42M |
| Geron Corp. | 248.71M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Vertex Pharmaceuticals, Inc. | 17.32B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.190B |
| Total Liabilities (Quarterly) | 1.174B |
| Debt to Equity Ratio | 94.24 |
| Current Ratio | 1.892 |
| Net Debt Paydown Yield | 0.44% |